A popular class of drugs for weight loss and Type 2 diabetes might help lower the prevalence of heart disease, according to a study published Dec. 18 in Cell Metabolism.
Read the full post on Becker's Hospital Review - Healthcare News
Wegovy, other GLP-1s could lower heart disease: Study
